Received Oct 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
Grover's disease; This spontaneous case was reported by a consumer and describes the occurrence of TRANSIENT ACANTHOLYTIC DERMATOSIS (Grover's disease) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 1 dosage form. In 2021, the patient experienced TRANSIENT ACANTHOLYTIC DERMATOSIS (Grover's disease). At the time of the report, TRANSIENT ACANTHOLYTIC DERMATOSIS (Grover's disease) outcome was unknown. No concomitant medication was reported. The patient was being diagnosed with Grover's disease for 4 years. The patient had suffered so bad with these sores on her face and everywhere. The sores were on her body, the vaginal area and face. The patient did not have her vaccination records, thus, all information regarding her doses were unknown. No treatment medication was reported. It was unknown if the patient experienced any additional symptoms/events. The reporter causality was not reported.